Clark Estates’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXN
NICM
RG
Clark Estates's ALXN Position: Q3 2021 in Review
Clark Estates sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 29,000 shares — an estimated $5.33M sold.
Clark Estates first reported a position in ALXN in Q3 2020 and held it in 4 quarters. The position peaked at $5.33M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.
- Clark Estates reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
- Clark Estates sold 29,000 Alexion Pharmaceuticals shares in Q3 2021, an estimated $5.33M.
- Clark Estates first reported a position in Alexion Pharmaceuticals in Q3 2020 and held it in 4 quarters.
- Clark Estates's Alexion Pharmaceuticals position peaked at $5.33M in Q2 2021.
- 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.
Based on Clark Estates's 13F filing for Q3 2021, filed 12 Nov 2021.